[Principles and limits of ACTH-cortisone therapy in neurology].
D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology / Q000627:therapeutic use*; D000324:Adrenocorticotropic Hormone / Q000008:administration & dosage / Q000009:adverse effects / Q000502:physiology / Q000627:therapeutic use*; D003348:Cortisone / Q000627:therapeutic use*; D003907:Dexamethasone / Q000627:therapeutic use; D004827:Epilepsy / Q000188:drug therapy; D005158:Facial Paralysis / Q000188:drug therapy; D006801:Humans; D006854:Hydrocortisone / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D009135:Muscular Diseases / Q000188:drug therapy; D009157:Myasthenia Gravis / Q000188:drug therapy; D009220:Myositis / Q000188:drug therapy; D009222:Myotonia / Q000188:drug therapy; D009422:Nervous System Diseases / Q000188:drug therapy*; D010523:Peripheral Nervous System Diseases / Q000188:drug therapy; D011115:Polyneuropathies / Q000188:drug therapy; D011239:Prednisolone / Q000627:therapeutic use; D011241:Prednisone / Q000627:therapeutic use; D011843:Radiculopathy / Q000188:drug therapy; D014221:Triamcinolone / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D014221:Triamcinolone; D003907:Dexamethasone; D000324:Adrenocorticotropic Hormone; D011239:Prednisolone; D003348:Cortisone; D011241:Prednisone; D006854:Hydrocortisone; D008775:Methylprednisolone
Grundzüge und Grenzen der ACTH-Kortison-Therapie in der Neurologie.